Fmr LLC Annexon, Inc. Transaction History
Fmr LLC
- $1.52 Trillion
- Q2 2024
A detailed history of Fmr LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Fmr LLC holds 8,299,720 shares of ANNX stock, worth $60.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,299,720
Previous 9,372,822
11.45%
Holding current value
$60.4 Million
Previous $67.2 Million
39.48%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ANNX
# of Institutions
157Shares Held
101MCall Options Held
3.73MPut Options Held
1.3M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$61.5 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$53.9 Million71.21% of portfolio
-
Bvf Inc San Francisco, CA7MShares$51 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$48 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$46.8 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $347M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...